Slagle Financial’s GSK GSK Stock Holding History

Slagle Financial’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-5,057	Closed	-$207K	–	112
2024 Q3	$207K	Sell	5,057 -277	-5%	-$11.3K	0.09%	109
2024 Q2	$205K	Sell	5,334 -714	-12%	-$30K	0.11%	106
2024 Q1	$259K	Sell	6,048 -7,192	-54%	-$297K	0.14%	91
2023 Q4	$245K	Buy	13,240 +5,653	+75%	+$203K	0.14%	99
2023 Q3	$275K	Sell	7,587 -2,658	-26%	-$94.3K	0.17%	92
2023 Q2	$365K	Buy	+10,245	New	+$367K	0.23%	79

Other funds holding GSK

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Slagle Financial's GSK Position: Q4 2024 in Review

Slagle Financial sold out of GSK (GSK) in Q4 2024, closing a stake of 5,057 shares — an estimated $207K sold.

Slagle Financial first reported a position in GSK in Q2 2023 and held it in 6 quarters. The position peaked at $365K in Q2 2023. 848 funds tracked by Wall St. Rank hold GSK as of Q4 2024.

Slagle Financial reported no remaining GSK position as of Q4 2024 after selling out during the quarter.
Slagle Financial sold 5,057 GSK shares in Q4 2024, an estimated $207K.
Slagle Financial first reported a position in GSK in Q2 2023 and held it in 6 quarters.
Slagle Financial's GSK position peaked at $365K in Q2 2023.
848 funds tracked by Wall St. Rank held GSK as of Q4 2024.

Based on Slagle Financial's 13F filing for Q4 2024, filed 12 Feb 2025.